Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery) (DHAPS)
Hyponatremia, Hyponatremic, Pituitary Tumor
About this trial
This is an interventional prevention trial for Hyponatremia focused on measuring hyponatremia, hyponatremic, pituitary tumor, transsphenoidal resection, pituitary surgery, pituitary
Eligibility Criteria
Inclusion Criteria:
• Any adult patient with a pituitary adenoma or cyst (either non-functioning, prolactin-secreting, growth hormone secreting, ACTH (adrenocorticotropic hormone)-secreting, gonadotropin secreting, or TSH secreting) scheduled to undergo pituitary resection.
Exclusion Criteria:
- Patients with a history of chronic hyponatremia
- Patients with a history of SIADH (syndrome of inappropriate antidiuretic hormone) , except if secondary to hypothyroidism or adrenal insufficiency, or in association with prior TSS
- Patients with diabetes insipidus or patients receiving DDAVP
- Patients without an intact thirst mechanism
- Patients with CKD (chronic kidney disease) stage III, IV or V
- Patients with untreated adrenal insufficiency or hypothyroidism
- Patients with class III or IV heart failure
Sites / Locations
- Barnes Jewish Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Fluid restricted
Non Fluid Restricted
Fluids will be stopped at 8am on POD 1 and patients will be started on a moderate fluid restriction on POD #3 based on their weight (1000 cc/24 hours for patients who weigh <=100 kg and 1200 cc/24 hours for patients who weigh > 100kg)
No fluid restriction